Does trulicity work?

Does Trulicity actually lower blood sugar and support weight loss?

Trulicity (dulaglutide) mimics the GLP-1 hormone to increase insulin release, slow gastric emptying, and reduce appetite. In clinical trials lasting 26 to 52 weeks, patients taking 1.5 mg weekly saw A1C drops of 1.0–1.4% and average weight losses of 2–4 kg compared with placebo or metformin alone. Larger doses (3 mg and 4.5 mg) produced greater reductions in both markers.

How long does it take for Trulicity to show results?

Blood-sugar improvements appear within 2–4 weeks, but peak A1C lowering usually occurs by week 12–16. Weight loss continues gradually for up to 12 months and then tends to plateau unless diet or exercise changes are maintained.

What side effects do patients report most often?

The most common complaints are mild-to-moderate nausea, diarrhea, and decreased appetite, especially during the first four to six weeks. These effects lessen for most people after dose increases. Pancreatitis and gallbladder disease remain rare but documented risks.

Does Trulicity keep working long term?

Data from extension studies show A1C and weight benefits are maintained for at least two years in patients who continue therapy. Discontinuation typically leads to rebound rises in A1C and partial regain of lost weight within months.

Can other GLP-1 drugs outperform Trulicity?

Head-to-head trials found semaglutide (Ozempic) produced larger A1C drops (about 0.4% more) and roughly twice the weight loss of dulaglutide at comparable doses. Tirzepatide (Mounjaro) shows still greater effects on both endpoints.

When does Trulicity’s patent protection end?

The primary U.S. patent covering the dulaglutide molecule expires in 2027, with additional formulation patents stretching into 2031. Biosimilar competition could begin as early as 2027 once regulatory exclusivity lapses.